Cirrhosis: Open Clinical Trials

1 protocols meet the specified criteria

OCR22283

Investigation of Efficacy and Safety of Semaglutide s.c. Once-weekly Versus Placebo in Subjects With Non-alcoholic Steatohepatitis and Compensated Liver Cirrhosis